StockData
Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc. (MD) stock

MDNYSEServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/303% above fair value
$31.13−0.76 (-2.38%)

Close on Nov 17, 2026Market cap $2.43BP/E 16.9Yield –

Pediatrix Medical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Pediatrix Medical's operating income for the twelve months ending Sep 30, 2026 was $212.58M, up 6.7% year over year. For fiscal 2025 it was $208.81M. Over ten years it grew -9.4% a year on average. The highest annual figure on record is $571.69M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$208.81M–
FY2024Dec 31, 2024-$68.71M-1038.6%
FY2023Dec 31, 2023$7.32M-95.8%
FY2022Dec 31, 2022$172.69M-14.9%
FY2021Dec 31, 2021$202.92M+106.8%
FY2020Dec 31, 2020$98.13M-42.9%
FY2019Dec 31, 2019$171.76M-30.9%
FY2018Dec 31, 2018$248.39M-45.4%
FY2017Dec 31, 2017$454.89M-20.4%
FY2016Dec 31, 2016$571.69M+2.5%
FY2015Dec 31, 2015$557.87M+8.7%
FY2014Dec 31, 2014$513.00M+13.5%
FY2013Dec 31, 2013$452.13M+16.1%
FY2012Dec 31, 2012$389.52M+9.6%
FY2011Dec 31, 2011$355.39M+13.6%
FY2010Dec 31, 2010$312.91M+8.3%
FY2009Dec 31, 2009$288.93M+19.4%
FY2008Dec 31, 2008$242.03M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$65.21M-4.2%
Q2 FY2026Jun 30, 2026$56.92M-4.9%
Q1 FY2026Mar 31, 2026$41.66M+29.8%
Q4 FY2025Dec 31, 2025$48.79M+24.2%
Q3 FY2025Sep 30, 2025$68.05M+101.2%
Q2 FY2025Jun 30, 2025$59.87M–
Q1 FY2025Mar 31, 2025$32.10M+102.0%
Q4 FY2024Dec 31, 2024$39.29M–
Q3 FY2024Sep 30, 2024$33.83M-16.0%
Q2 FY2024Jun 30, 2024-$157.72M-425.2%
Q1 FY2024Mar 31, 2024$15.89M-47.1%
Q4 FY2023Dec 31, 2023-$111.49M-409.4%
Q3 FY2023Sep 30, 2023$40.27M-15.0%
Q2 FY2023Jun 30, 2023$48.50M-3.3%
Q1 FY2023Mar 31, 2023$30.04M-23.2%
Q4 FY2022Dec 31, 2022$36.04M-47.0%
Q3 FY2022Sep 30, 2022$47.39M-19.4%
Q2 FY2022Jun 30, 2022$50.16M+0.3%
Q1 FY2022Mar 31, 2022$39.11M+49.8%
Q4 FY2021Dec 31, 2021$68.01M+110.5%
Q3 FY2021Sep 30, 2021$58.79M+187.4%
Q2 FY2021Jun 30, 2021$50.02M+44.7%
Q1 FY2021Mar 31, 2021$26.10M+141.6%
Q4 FY2020Dec 31, 2020$32.31M-19.5%
Q3 FY2020Sep 30, 2020$20.46M-57.9%
Q2 FY2020Jun 30, 2020$34.57M-19.7%
Q1 FY2020Mar 31, 2020$10.80M-73.0%
Q4 FY2019Dec 31, 2019$40.14M-62.0%
Q3 FY2019Sep 30, 2019$48.57M-53.4%
Q2 FY2019Jun 30, 2019$43.06M-64.8%
Q1 FY2019Mar 31, 2019$39.99M-59.9%
Q4 FY2018Dec 31, 2018$105.55M-16.0%
Q3 FY2018Sep 30, 2018$104.21M-17.6%
Q2 FY2018Jun 30, 2018$122.39M+0.4%
Q1 FY2018Mar 31, 2018$99.66M-6.0%
Q4 FY2017Dec 31, 2017$125.70M-12.0%
Q3 FY2017Sep 30, 2017$126.43M–
Q2 FY2017Jun 30, 2017$121.90M–
Q1 FY2017Mar 31, 2017$106.04M–
Q4 FY2016Dec 31, 2016$142.78M–

More Pediatrix Medical figures

See a number that looks wrong?